OncoTICE, Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung

7680525630383 CH-52563 Pulver
OncoTICE, Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/01/2026
Summary of Product Characteristics
Français
29/01/2026
Summary of Product Characteristics
Italien
29/01/2026

Detailed composition

Substance Quantity Type Category
bacillus Calmette-Guérin (BCG) vivus attenuatum (TICE)
- Substance Wirkstoff (Principe actif)
lactosum monohydricum
- Substance HNIDK
asparaginum monohydricum
- Substance HNIDK
acidum citricum monohydricum
- Substance HNIDK
dikalii phosphas anhydricus
- Substance HNIDK
magnesii sulfas heptahydricus
- Substance HNIDK
ammonii ferri citras
- Substance HNIDK
glycerolum
- Substance HNIDK
ammonii hydroxidum
- Substance HNIDK
zinci formicas
- Substance HNIDK

Reimbursement information

Public price
CHF 122.50
Specialties list
Yes
Generic
No
SL addition date: 15/03/1997

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
52563
Drug name
OncoTICE, Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung
Galenic form
PULVIV
ATC Code
L03AX03
Authorization status
Z
Dispensing category
A
First authorization
16/11/1994
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
BCG-Immunotherapeutikum zur Behandlung des In-situ-Karzinoms der Harnblase

Package details

Description (FR)
ONCOTICE poudre pour suspension intravésicale 1 pc
Description (DE)
ONCOTICE Pulver zur Herstellung einer Suspensionen
Market launch
16/11/1994
Narcotic (BTM)
No
Buy us a coffee Explore the data